ELAB:NASDAQ, PMGC Holdings Inc.
ELAB stock overview
PMGC Holdings Inc. (ELAB:NASDAQ) closed at $2.71 on October 23, 2026,
up 0.52% on the day.
The stock trades 99.8% below its 52-week high of $1,537.44
and 4.7% above its 52-week low of $2.59.
Over the past year, it lost 98.1%.
PMGC Holdings Inc. is part of the Consumer Non-Durables sector.
Key figures
- Price
- $2.71
- Day change
- +0.52%
- Volume
- 1,311
- Average volume
- 46,626
- Market cap
- 2M+
- 52-week range
- $2.59 – $1,537.44
- 50-day average
- $4.67
- 200-day average
- $44.31
Price action over the past year
In 252 trading sessions since October 23, 2025, ELAB closed higher on 82 days (33%).
Its best day was February 23, 2026 (+837.98%) and its worst was April 2, 2026 (-59.14%).
The stock moved 10% or more in a single session 43 times.
It opened at least 5% above the previous day's high 9 times.
Recent signals
ELAB news
-
Oct 8, 2026:
PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update
-
Oct 1, 2026:
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy
-
Oct 1, 2026:
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy
-
Sep 29, 2026:
NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
-
Sep 18, 2026:
PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
-
Sep 1, 2026:
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
-
Aug 26, 2026:
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
-
Aug 25, 2026:
PMGC Holdings Signs Orbit2Orbit Term Sheet for Microgravity Muscle Research
About PMGC Holdings Inc.
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Similar stocks
Find more stocks like ELAB with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.